Aethelon Medical Files 8-K
Ticker: AEMD · Form: 8-K · Filed: Apr 25, 2024 · CIK: 882291
| Field | Detail |
|---|---|
| Company | Aethlon Medical Inc (AEMD) |
| Form Type | 8-K |
| Filed Date | Apr 25, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, corporate-update
TL;DR
Aethelon Medical filed an 8-K on 4/25/24. Standard update.
AI Summary
Aethelon Medical, Inc. filed an 8-K on April 25, 2024, reporting other events and financial statements. The company, incorporated in Nevada, has its principal executive offices in San Diego, California.
Why It Matters
This filing indicates Aethelon Medical is providing updates on its corporate activities and financial status to the SEC.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically reports significant corporate events or financial updates.
Key Players & Entities
- AETHLON MEDICAL, INC. (company) — Registrant
- Nevada (jurisdiction) — State of Incorporation
- San Diego, California (location) — Principal Executive Offices
- April 25, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing for Aethelon Medical, Inc.?
The filing is a Current Report on Form 8-K, reporting 'Other Events' and 'Financial Statements and Exhibits' as of April 25, 2024.
When was the earliest event reported in this filing?
The earliest event reported was on April 25, 2024.
Where are Aethelon Medical, Inc.'s principal executive offices located?
The principal executive offices are located at 11555 Sorrento Valley Road, Suite 203, San Diego, California 92121.
In which state was Aethelon Medical, Inc. incorporated?
Aethelon Medical, Inc. was incorporated in Nevada.
What is the company's IRS Employer Identification Number?
The IRS Employer Identification Number for Aethelon Medical, Inc. is 13-3632859.
Filing Stats: 443 words · 2 min read · ~1 pages · Grade level 10.3 · Accepted 2024-04-25 08:00:15
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share AEMD The Nasdaq
Filing Documents
- aethlon_8k.htm (8-K) — 26KB
- aethlon_ex9901.htm (EX-99.1) — 33KB
- image_002.jpg (GRAPHIC) — 74KB
- image_003.jpg (GRAPHIC) — 371KB
- image_004.jpg (GRAPHIC) — 135KB
- image_005.jpg (GRAPHIC) — 180KB
- image_006.jpg (GRAPHIC) — 220KB
- image_007.jpg (GRAPHIC) — 145KB
- image_008.jpg (GRAPHIC) — 174KB
- image_009.jpg (GRAPHIC) — 166KB
- image_010.jpg (GRAPHIC) — 155KB
- image_011.jpg (GRAPHIC) — 219KB
- image_012.jpg (GRAPHIC) — 133KB
- image_013.jpg (GRAPHIC) — 195KB
- image_014.jpg (GRAPHIC) — 160KB
- image_015.jpg (GRAPHIC) — 184KB
- image_016.jpg (GRAPHIC) — 121KB
- image_017.jpg (GRAPHIC) — 115KB
- image_018.jpg (GRAPHIC) — 171KB
- image_019.jpg (GRAPHIC) — 224KB
- image_020.jpg (GRAPHIC) — 167KB
- image_021.jpg (GRAPHIC) — 93KB
- image_022.jpg (GRAPHIC) — 161KB
- image_023.jpg (GRAPHIC) — 97KB
- 0001683168-24-002672.txt ( ) — 5281KB
- aemd-20240425.xsd (EX-101.SCH) — 3KB
- aemd-20240425_lab.xml (EX-101.LAB) — 33KB
- aemd-20240425_pre.xml (EX-101.PRE) — 22KB
- aethlon_8k_htm.xml (XML) — 4KB
01
Item 8.01 Other Events. On April 25, 2024, Aethlon Medical, Inc. (the "Company") updated its corporate presentation for use in meetings with investors, analysts and others. The presentation is available through the Company's website and a copy is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Company Presentation, dated April 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 25, 2024 Aethlon Medical, Inc. By: /s/ James B. Frakes Name: James B. Frakes Interim Chief Executive Officer and Chief Financial Officer 3